Literature DB >> 12398543

Assessment of the antiprotozoal activity of Galphimia glauca and the isolation of new nor-secofriedelanes and nor-friedelanes.

Maria del Rayo Camacho1, J David Phillipson, Simon L Croft, Dereck Marley, Geoffrey C Kirby, David C Warhurst.   

Abstract

Four new terpenoids, comprising three nor-secofriedelanes (1-3) and one nor-friedelane (4), were isolated from Galphimia glauca, together with the known flavonol quercetin and the sterols stigmasterol and sitosterol 3-O-beta-D-glucoside. The structure elucidation of the new isolates was conducted by 1D and 2D NMR techniques. Compounds 1-4 were given the trivial names galphin A, galphin B, galphin C, and galphimidin, respectively. All isolates were tested for in vitro antiprotozoal and cytotoxic activities. Quercetin was the only substance isolated that showed any antiprotozoal activity, and this was weak; the IC(50) values were 14 microM against Plasmodium falciparum K1, 13.2 microM against Trypanosoma brucei brucei, and 63.8 microM against Leishmania donovani. Quercetin was found to be inactive against KB cells (IC(50) = 295.8 microM).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12398543     DOI: 10.1021/np010419i

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  8 in total

1.  Antitrypanosomal and antileishmanial activities of flavonoids and their analogues: in vitro, in vivo, structure-activity relationship, and quantitative structure-activity relationship studies.

Authors:  Deniz Tasdemir; Marcel Kaiser; Reto Brun; Vanessa Yardley; Thomas J Schmidt; Fatma Tosun; Peter Rüedi
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

2.  In vitro and in vivo assessment of the anti-malarial activity of Caesalpinia pluviosa.

Authors:  Ana Carolina A V Kayano; Stefanie C P Lopes; Fernanda G Bueno; Elaine C Cabral; Wanessa C Souza-Neiras; Lucy M Yamauchi; Mary A Foglio; Marcos N Eberlin; João Carlos P Mello; Fabio T M Costa
Journal:  Malar J       Date:  2011-05-02       Impact factor: 2.979

Review 3.  Multidisciplinary Investigations on Galphimia glauca: A Mexican Medicinal Plant with Pharmacological Potential.

Authors:  Ashutosh Sharma; Paola Isabel Angulo-Bejarano; Alfredo Madariaga-Navarrete; Goldie Oza; Hafiz M N Iqbal; Alexandre Cardoso-Taketa; Maria Luisa Villarreal
Journal:  Molecules       Date:  2018-11-15       Impact factor: 4.411

Review 4.  The Role of Natural Products in Drug Discovery and Development against Neglected Tropical Diseases.

Authors:  Peter Mubanga Cheuka; Godfrey Mayoka; Peggoty Mutai; Kelly Chibale
Journal:  Molecules       Date:  2016-12-31       Impact factor: 4.411

5.  Vasodilator Activity of Compounds Isolated from Plants Used in Mexican Traditional Medicine.

Authors:  Francisco J Luna-Vázquez; César Ibarra-Alvarado; María Del Rayo Camacho-Corona; Alejandra Rojas-Molina; J Isela Rojas-Molina; Abraham García; Moustapha Bah
Journal:  Molecules       Date:  2018-06-18       Impact factor: 4.411

6.  Biochemical characterization and chemical validation of Leishmania MAP Kinase-3 as a potential drug target.

Authors:  Shweta Raj; Gundappa Saha; Santanu Sasidharan; Vikash Kumar Dubey; Prakash Saudagar
Journal:  Sci Rep       Date:  2019-11-07       Impact factor: 4.379

Review 7.  Natural Products That Target the Arginase in Leishmania Parasites Hold Therapeutic Promise.

Authors:  Nicola S Carter; Brendan D Stamper; Fawzy Elbarbry; Vince Nguyen; Samuel Lopez; Yumena Kawasaki; Reyhaneh Poormohamadian; Sigrid C Roberts
Journal:  Microorganisms       Date:  2021-01-28

8.  Identification of Putative Candidate Genes from Galphimia spp. Encoding Enzymes of the Galphimines Triterpenoids Synthesis Pathway with Anxiolytic and Sedative Effects.

Authors:  Dianella Iglesias; Marcos de Donato Capote; Alfonso Méndez Tenorio; Ana Victoria Valdivia; Claudia Gutiérrez-García; Sujay Paul; Hafiz M N Iqbal; María Luisa Villarreal; Ashutosh Sharma
Journal:  Plants (Basel)       Date:  2022-07-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.